NFKB1 and cancer: Diminishing NF‐κB activity and subsequent SASP expression largely reduces the clearance of senescent cancer cells and causes them to accumulate in vivo and eventually leads to cancer relapse (Chien et al., 2011; Jing et al., 2011).